|Bid||266.39 x 1100|
|Ask||266.49 x 800|
|Day's range||265.85 - 267.34|
|52-week range||217.68 - 271.15|
|Beta (5Y monthly)||0.56|
|PE ratio (TTM)||32.86|
|Earnings date||25 Oct 2022 - 31 Oct 2022|
|Forward dividend & yield||5.52 (2.07%)|
|Ex-dividend date||31 Aug 2022|
|1y target est||281.42|
Bristol Myers is a top drugmaker that investors can count on for long-term growth and dividend income. In its most recent quarter, for the period ended June 30, the company reported revenue of $11.9 billion that rose 2% year over year. The company's continued innovation makes it a promising investment.
Western companies with iconic brands like Coca-Cola that exit Russia face years of battling knockoffs and unauthorized imports clamoring to fill the void they leave behind, a risky bid as courts show little sympathy for firms that depart. Companies pulled back from Russia this spring after Moscow sent thousands of troops into Ukraine, in response to investor and public pressure. They are defending their trademarks to protect their brands from losing value, and in case they ever return to the country, intellectual property lawyers said.
Food reporter Brooke DiPalma outlines where grocery prices are outpacing inflation seen in restaurant menus, including fast food prices and how water shortages threaten this year's tomato harvests.